Senate Candidate Faced Backlash Over 2012 Research Essay
A 2012 essay by Abdul El-Sayed regarding breast cancer research funding surfaced during the Michigan Senate race.
Updated on Sept. 19, 2026 in Cancer
Live Poll
Should federal health research funding be determined primarily by objective health metrics rather than advocacy groups?
On September 18, 2026, a 2012 essay written by Michigan Senate candidate Abdul El-Sayed surfaced, drawing criticism from political opponents. In the piece, titled The Pink Ribbon Lobby and Everyone Else, the former Columbia University assistant professor challenged federal funding priorities for breast cancer research.
Why it matters
The controversy centers on El-Sayed's past argument that federal health agencies disproportionately allocate funding based on the advocacy power of specific groups rather than equitable health metrics. Opponents are using the resurfaced writing to question his approach to public health policy.
Nationwide, men account for less than 1% of all breast cancer diagnoses, totaling approximately 2,670 cases per year. This corresponds to a lifetime risk of 0.13%, or roughly 1 in 755 for men.
The players
Abdul El-Sayed
He is a Michigan Senate candidate and former assistant professor of epidemiology at Columbia University.
Mike Rogers
He is the Republican nominee for the Michigan U.S. Senate seat who previously served in the U.S. Army and as an FBI Special Agent.
The details
El-Sayed, who served as an assistant professor of epidemiology at Columbia University when he authored the essay, argued that the prominence of breast cancer advocacy created an exaggerated sense of alarm. He maintained that public health resources should be distributed according to objective health impacts rather than the influence of advocacy groups.
Timeline
1985-1989: Mike Rogers served in the United States Army.
1989-1994: Mike Rogers worked as an FBI Special Agent.
2012: El-Sayed authored the essay on breast cancer funding.
September 18, 2026: The essay surfaced during the Michigan Senate campaign.
Health Landscape
This dispute over research funding touches on the broader tension between advocacy-driven medical investment and objective epidemiological health metrics. It highlights how past academic criticisms can shape political scrutiny regarding federal resource allocation for chronic diseases like breast cancer.
While the debate is political, it raises questions about how federal health agencies determine which conditions receive priority for research and funding. Residents may see this influence current platform stances on how health resources are distributed across the state.
The takeaway
The surfacing of this essay demonstrates how past academic work is increasingly leveraged to challenge the policy stances of modern political candidates. Voters are encouraged to examine the full context of past writings when evaluating a candidate's current approach to healthcare equity.
Further reading
Explore ongoing discussions regarding cancer policy in the Michigan Cancer section.
Live Poll
Should federal health research funding be determined primarily by objective health metrics rather than advocacy groups?
